1. Home
  2. RES vs ALVO Comparison

RES vs ALVO Comparison

Compare RES & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$6.74

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

SELL

Current Price

$4.95

Market Cap

1.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RES
ALVO
Founded
1984
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
RES
ALVO
Price
$6.74
$4.95
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$6.40
★ $7.20
AVG Volume (30 Days)
★ 2.1M
935.0K
Earning Date
10-29-2026
11-11-2026
Dividend Yield
★ 2.42%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.06
N/A
Revenue
★ $41,919,000,000.00
N/A
Revenue This Year
$13.23
$10.83
Revenue Next Year
$0.79
$20.41
P/E Ratio
$110.42
★ $18.20
Revenue Growth
★ 2216.21
N/A
52 Week Low
$5.00
$2.94
52 Week High
$8.16
$7.92

Technical Indicators

Market Signals
Indicator
RES
ALVO
Relative Strength Index (RSI) 68.97 44.65
Support Level $6.79 $4.90
Resistance Level $7.38 $5.48
Average True Range (ATR) 0.25 0.26
MACD 0.08 -0.09
Stochastic Oscillator 100.00 31.75

Price Performance

Historical Comparison
RES
ALVO

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: